Penumbra Investor Relations Material
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company operates through two segments, Ventricular Assistive (VAD) Systems Group and Neurovascular Intervention Devices Group. As of December 31, 2006, its VAD Systems Group segment sold cardiovascular support systems comprising left ventricular assist devices; tissue heart pumps; heart assist blood pumps; ventricular assist blood pumps; and centrifugal blood pumps to hospitals and distributors in the United States and internationally. The Neurovascular Intervention Devices Group segment produces balloon angioplasty catheters and tools for treatment of vascular stenosis; electrosurgical pads for endovascular surgical procedures; ultrasound imaging products for carotid artery disease screening and diagnostic applications; and instruments for neurovascular surgery. In addition, this segment provides maintenance service contracts under which customers can lease equipment to replace their long-term commitments with capital equipment ownership. The company markets its products directly to physicians in the United States through in-person sales visits by its representatives.
Edward "Ted" Decker's Rise to the Top at Home Depot
Explore Ted Decker's transformative impact on Home Depot, including his leadership in retail innovation and strategic vision alongside Craig Menear.
15 Feb 2024
Andy Jassy: Amazon CEO & Pioneer of Cloud Computing
Discover Andy Jassy's remarkable achievements at Amazon, including the creation of Amazon Web Services and his experiences working with Jeff Bezos.
15 Feb 2024
Stripe’s Rumored 2024 IPO
Anticipation grows around Stripe's rumored 2024 IPO, spotlighting its significant influence in the digital payments sector.
9 Feb 2024
🇺🇸 United States